Skip to main content
. 2022 Oct 24;482(1):281–298. doi: 10.1007/s00428-022-03421-5

Table 3.

Incidence of MYD88 and CD79B mutations in primary cutaneous diffuse large B cell lymphoma, leg type compared to other subtypes of large B cell lymphoma (incidences from Wright et al. [3])

PCDLBCL-LT Primary CNS DLBCL Primary testicular DLBCL Intravascular LBCL DLBCL in breast MCD DLBCL All nodal DLBCL
MYD88 59% 61% 67% 47% 50% 66% 11%
CD79B 43% 42% 16% 38% 29% 50% 11%
MYD88 + CD79B 38% 29% 16% 24% 17% 38% 4%

PCDLBCL-LT primary cutaneous diffuse large B cell lymphoma, leg type; DLBCL diffuse large B cell lymphoma; LBCL large B cell lymphoma